Ann: Atomo and Access Bio renegotiate supply agreements, page-22

well, I was wrong... Mr Market not happy

they see (as noted above by you wise people) Atomo has virtually nil market going forward for the antibody test; I thought Mr Market would view they sugar hit (from the material payment) and the new supply channel for the antigen tests as more a positive compared to the negative

I really am befuddled the 34 cent AT1 price had anything priced in for ongoing antibody supply; I would have guessed the 34 cents (before announcement) would go up as we got a break fee and the antigen side looks good.. to the tune of 10 mill plus 10 mill tests... heck if you make $1 a test, that is good

Mr Market you are dumb (maybe?); again, Mr Market can be dumb as long as financially we make money... but Atomo has not made any money to counter sentiment